Evidence map›Paper›PMID 29083379›Full record

ArticleMedical sciences (Basel, Switzerland)2016

Androgen Receptor Expression in Thai Breast Cancer Patients.

Suthat Chottanapund, M B M Van Duursen, Kumpol Ratchaworapong, Panida Navasumrit, Mathuros Ruchirawat, Martin Van den Berg

Open access · goldAbstract read
In one paragraph

Article in Medical sciences (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Suthat ChottanapundDivision of Environmental Toxicology, Chulabhorn Graduate Institute, Bangkok 10210, Thailand. suthat.c@bidi.mail.go.th.ORCID 0000-0001-6630-4339
M B M Van DuursenInstitute for Risk Assessment Sciences, Utrecht University, Utrecht NL-3508, The Netherlands. m.vanduursen@uu.nl.ORCID 0000-0002-3838-9731
Kumpol RatchaworapongDepartment of Surgery, Charoenkrung Pracharuk Hospital, Bangkok 10120, Thailand. siajeab@hotmail.com.
Panida NavasumritDivision of Environmental Toxicology, Chulabhorn Graduate Institute, Bangkok 10210, Thailand. panida@cri.or.th.
Mathuros RuchirawatDivision of Environmental Toxicology, Chulabhorn Graduate Institute, Bangkok 10210, Thailand. mathuros@cri.or.th.
Martin Van den BergInstitute for Risk Assessment Sciences, Utrecht University, Utrecht NL-3508, The Netherlands. m.vandenberg@uu.nl.ORCID 0000-0001-6239-6301
Chulabhorn Graduate Institute · THUtrecht University · NLCharoenkrung Pracharak Hospital · THMinistry of Public Health · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to investigate prevalence and related factors of androgen receptor (AR) expression in Thai breast cancer patients. A descriptive study was done in 95 patients, who were admitted to Charoenkrung Pracharak Hospital, Bangkok (2011-2013). Statistical relationships were examined between AR protein expression, tumor status, and patient characteristics. Compared with those from Western countries, ethnic Thai patients were younger at age of diagnosis and had a higher proliferative index (high Ki-67 expression), which indicates unfavorable prognosis. In addition, 91% of the Thai breast tumors that were positive for any of the following receptors, estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) also expressed the AR protein, while in triple negative breast tumors only 33% were AR positive. ER and PR expression was positively related with AR expression, while AR expression was inversely correlated to Ki-67 expression. AR status was strongly correlated with ER and PR status in Thai patients. There is an inverse relationship between Ki-67 and AR, which suggests that AR may be a prognostic factor for breast cancer.

Indexed as

androgen receptorsandrogensbreast cancer

Identifiers

PMID29083379
PMCPMC5635797
OpenAlexW2519778946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.